These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 165942)

  • 61. Tamoxifen is a potent "pure" anti-oestrogen in chick oviduct.
    Sutherland R; Mester J; Baulieu EE
    Nature; 1977 Jun; 267(5610):434-5. PubMed ID: 876358
    [No Abstract]   [Full Text] [Related]  

  • 62. Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata.
    Powell-Jones W; Jenner DA; Blamey RW; Davies P; Griffiths K
    Biochem J; 1975 Jul; 150(1):71-5. PubMed ID: 173302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of phospholipid turnover by steroid hormones in endometrial carcinoma and breast cancer cells.
    Krasil'nikov MA; Shatskaya VA; Kuzmina ZV; Barinov VV; Letyagin VP; Bassalyk LS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):543-8. PubMed ID: 8393260
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.
    Brooks SC; Locke ER; Soule HD
    J Biol Chem; 1973 Sep; 248(17):6251-3. PubMed ID: 4353636
    [No Abstract]   [Full Text] [Related]  

  • 66. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Similarity of the estrogen receptor in human and rat mammary carcinoma.
    McGuire WL; DeLaGarza M
    J Clin Endocrinol Metab; 1973 Mar; 36(3):548-52. PubMed ID: 4346606
    [No Abstract]   [Full Text] [Related]  

  • 68. [Nuclear functions of normal and adenocarcinomatous cells of the endometrium and the regulatory mechanism of steroid hormones].
    Nishiya I
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Aug; 35(8):1156-65. PubMed ID: 6619611
    [No Abstract]   [Full Text] [Related]  

  • 69. Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.
    Wiseman LR; Johnson MD; Wakeling AE; Lykkesfeldt AE; May FE; Westley BR
    Eur J Cancer; 1993; 29A(16):2256-64. PubMed ID: 8110496
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
    Rochefort H; Capony F
    Biochem Biophys Res Commun; 1977 Mar; 75(2):277-85. PubMed ID: 557979
    [No Abstract]   [Full Text] [Related]  

  • 71. Estrogen receptors in human breast cancer.
    McGuire WL
    J Clin Invest; 1973 Jan; 52(1):73-7. PubMed ID: 4345203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oestrogen-like effect of tamoxifen on vaginal epithelium.
    Ferrazzi E; Cartei G; Mattarazzo R; Fiorentino M
    Br Med J; 1977 May; 1(6072):1351-2. PubMed ID: 861624
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytosol oestradiol and progesterone receptors in endometrial hyperplasia and adenocarcinoma: determination by single saturating dose exchange assays.
    Elliott PM; Krozowski Z; Jansen RP
    Aust N Z J Obstet Gynaecol; 1980 Nov; 20(4):199-204. PubMed ID: 6940562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Interaction of norethindrone on estrogen and progesterone receptors in the rabbit uterine cytosol (author's transl)].
    Tamaya T; Ishihara S; Motoyama T; Nioka S; Furuta N
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1033-42. PubMed ID: 183990
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women.
    Sakai F; Saez S
    Steroids; 1976 Jan; 27(1):99-110. PubMed ID: 178073
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oestrogen-responsive human breast cancer in long term tissue culture.
    Lippman ME; Bolan G
    Nature; 1975 Aug; 256(5518):592-3. PubMed ID: 170527
    [No Abstract]   [Full Text] [Related]  

  • 77. Ligand-induced change in sedimentation behavior of human progestin receptors.
    ElDeib MM; Costlow ME; Andersen RN
    Steroids; 1983 Dec; 42(6):687-705. PubMed ID: 6098979
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of enzymes on the estrogen receptors of human uterus and breast carcinoma.
    Hähnel R; Twaddle E; Brindle L
    Steroids; 1974 Oct; 24(4):489-506. PubMed ID: 4371127
    [No Abstract]   [Full Text] [Related]  

  • 79. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
    Oesterreich S; Zhang Q; Hopp T; Fuqua SA; Michaelis M; Zhao HH; Davie JR; Osborne CK; Lee AV
    Mol Endocrinol; 2000 Mar; 14(3):369-81. PubMed ID: 10707955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.